356 related articles for article (PubMed ID: 30655217)
1. The role of C16:0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach.
Raichur S; Brunner B; Bielohuby M; Hansen G; Pfenninger A; Wang B; Bruning JC; Larsen PJ; Tennagels N
Mol Metab; 2019 Mar; 21():36-50. PubMed ID: 30655217
[TBL] [Abstract][Full Text] [Related]
2. Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.
Turpin SM; Nicholls HT; Willmes DM; Mourier A; Brodesser S; Wunderlich CM; Mauer J; Xu E; Hammerschmidt P; Brönneke HS; Trifunovic A; LoSasso G; Wunderlich FT; Kornfeld JW; Blüher M; Krönke M; Brüning JC
Cell Metab; 2014 Oct; 20(4):678-86. PubMed ID: 25295788
[TBL] [Abstract][Full Text] [Related]
3. Ceramide Synthase 5 Is Essential to Maintain C16:0-Ceramide Pools and Contributes to the Development of Diet-induced Obesity.
Gosejacob D; Jäger PS; Vom Dorp K; Frejno M; Carstensen AC; Köhnke M; Degen J; Dörmann P; Hoch M
J Biol Chem; 2016 Mar; 291(13):6989-7003. PubMed ID: 26853464
[TBL] [Abstract][Full Text] [Related]
4. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
[TBL] [Abstract][Full Text] [Related]
5. Ceramide Synthase 6 Is a Novel Target of Methotrexate Mediating Its Antiproliferative Effect in a p53-Dependent Manner.
Fekry B; Esmaeilniakooshkghazi A; Krupenko SA; Krupenko NI
PLoS One; 2016; 11(1):e0146618. PubMed ID: 26783755
[TBL] [Abstract][Full Text] [Related]
6. CerS1-Derived C
Turpin-Nolan SM; Hammerschmidt P; Chen W; Jais A; Timper K; Awazawa M; Brodesser S; Brüning JC
Cell Rep; 2019 Jan; 26(1):1-10.e7. PubMed ID: 30605666
[TBL] [Abstract][Full Text] [Related]
7. CerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity.
Hammerschmidt P; Ostkotte D; Nolte H; Gerl MJ; Jais A; Brunner HL; Sprenger HG; Awazawa M; Nicholls HT; Turpin-Nolan SM; Langer T; Krüger M; Brügger B; Brüning JC
Cell; 2019 May; 177(6):1536-1552.e23. PubMed ID: 31150623
[TBL] [Abstract][Full Text] [Related]
8. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
[TBL] [Abstract][Full Text] [Related]
9. Ceramide synthase 6 mediates sex-specific metabolic response to dietary folic acid in mice.
Barron K; Ogretmen B; Krupenko N
J Nutr Biochem; 2021 Dec; 98():108832. PubMed ID: 34358645
[TBL] [Abstract][Full Text] [Related]
10. The effects of restraint stress on ceramide metabolism disorders in the rat liver: the role of CerS6 in hepatocyte injury.
Liu Y; Sun Z; Sun Q; Wang L; Wang C; Li Y; Ma C; Shi W; Zhang G; Dong Y; Zhang X; Cong B
Lipids Health Dis; 2024 Mar; 23(1):68. PubMed ID: 38431645
[TBL] [Abstract][Full Text] [Related]
11. Multiple antisense oligonucleotides targeted against monoacylglycerol acyltransferase 1 (Mogat1) improve glucose metabolism independently of Mogat1.
Lutkewitte AJ; Singer JM; Shew TM; Martino MR; Hall AM; He M; Finck BN
Mol Metab; 2021 Jul; 49():101204. PubMed ID: 33676028
[TBL] [Abstract][Full Text] [Related]
12. Ceramide synthase-6 confers resistance to chemotherapy by binding to CD95/Fas in T-cell acute lymphoblastic leukemia.
Verlekar D; Wei SJ; Cho H; Yang S; Kang MH
Cell Death Dis; 2018 Sep; 9(9):925. PubMed ID: 30206207
[TBL] [Abstract][Full Text] [Related]
13. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789
[TBL] [Abstract][Full Text] [Related]
14. Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner.
Tirodkar TS; Lu P; Bai A; Scheffel MJ; Gencer S; Garrett-Mayer E; Bielawska A; Ogretmen B; Voelkel-Johnson C
J Biol Chem; 2015 May; 290(21):13157-67. PubMed ID: 25839235
[TBL] [Abstract][Full Text] [Related]
15. Cigarette smoke exposure impairs β-cell function through activation of oxidative stress and ceramide accumulation.
Tong X; Chaudhry Z; Lee CC; Bone RN; Kanojia S; Maddatu J; Sohn P; Weaver SA; Robertson MA; Petrache I; Evans-Molina C; Kono T
Mol Metab; 2020 Jul; 37():100975. PubMed ID: 32283079
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide treatment produces a type I interferon response that protects against diet-induced obesity.
McCabe KM; Hsieh J; Thomas DG; Molusky MM; Tascau L; Feranil JB; Qiang L; Ferrante AW; Tall AR
Mol Metab; 2020 Apr; 34():146-156. PubMed ID: 32180554
[TBL] [Abstract][Full Text] [Related]
17. A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis.
Williams B; Correnti J; Oranu A; Lin A; Scott V; Annoh M; Beck J; Furth E; Mitchell V; Senkal CE; Obeid L; Carr RM
FASEB J; 2018 Jan; 32(1):130-142. PubMed ID: 28864659
[TBL] [Abstract][Full Text] [Related]
18. CerS6-dependent ceramide synthesis in hypothalamic neurons promotes ER/mitochondrial stress and impairs glucose homeostasis in obese mice.
Hammerschmidt P; Steculorum SM; Bandet CL; Del Río-Martín A; Steuernagel L; Kohlhaas V; Feldmann M; Varela L; Majcher A; Quatorze Correia M; Klar RFU; Bauder CA; Kaya E; Porniece M; Biglari N; Sieben A; Horvath TL; Hornemann T; Brodesser S; Brüning JC
Nat Commun; 2023 Nov; 14(1):7824. PubMed ID: 38016943
[TBL] [Abstract][Full Text] [Related]
19. Alteration of ceramide synthase 6/C16-ceramide induces activating transcription factor 6-mediated endoplasmic reticulum (ER) stress and apoptosis via perturbation of cellular Ca2+ and ER/Golgi membrane network.
Senkal CE; Ponnusamy S; Manevich Y; Meyers-Needham M; Saddoughi SA; Mukhopadyay A; Dent P; Bielawski J; Ogretmen B
J Biol Chem; 2011 Dec; 286(49):42446-42458. PubMed ID: 22013072
[TBL] [Abstract][Full Text] [Related]
20. Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases.
Kim YR; Lee EJ; Shin KO; Kim MH; Pewzner-Jung Y; Lee YM; Park JW; Futerman AH; Park WJ
Exp Mol Med; 2019 Nov; 51(11):1-16. PubMed ID: 31676768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
